Cardiff Oncology, Inc. (CRDF)
NASDAQ: CRDF · Real-Time Price · USD
4.160
+0.080 (1.96%)
At close: Jul 10, 2025, 4:00 PM
4.150
-0.010 (-0.24%)
Pre-market: Jul 11, 2025, 5:33 AM EDT
Cardiff Oncology Market Cap
Cardiff Oncology has a market cap or net worth of $276.75 million as of July 11, 2025. Its market cap has increased by 152.51% in one year.
Market Cap
276.75M
Enterprise Value
198.22M
1-Year Change
152.51%
Ranking
Category
Stock Price
$4.16
Market Cap Chart
Since June 20, 2007, Cardiff Oncology's market cap has decreased from $1.11B to $276.75M, a decrease of -75.05%. That is a compound annual growth rate of -7.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 9, 2025 | 271.40M | 22.31% |
| Dec 31, 2024 | 221.90M | 235.70% |
| Dec 29, 2023 | 66.10M | 5.76% |
| Dec 30, 2022 | 62.50M | -73.71% |
| Dec 31, 2021 | 237.70M | -62.60% |
| Dec 31, 2020 | 635.50M | 6,519.79% |
| Dec 31, 2019 | 9.60M | -20.66% |
| Dec 31, 2018 | 12.10M | 3.42% |
| Dec 29, 2017 | 11.70M | -81.80% |
| Dec 30, 2016 | 64.30M | -59.94% |
| Dec 31, 2015 | 160.50M | 97.42% |
| Dec 31, 2014 | 81.30M | -25.07% |
| Dec 31, 2013 | 108.50M | 10.38% |
| Dec 31, 2012 | 98.30M | 166.40% |
| Dec 30, 2011 | 36.90M | 5.73% |
| Dec 31, 2010 | 34.90M | -93.61% |
| Dec 31, 2008 | 546.30M | -50.74% |
| Dec 31, 2007 | 1.11B | - |
View and export this data all the way back to 2007.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 702.12B |
| Johnson & Johnson | 373.93B |
| AbbVie | 336.39B |
| Novo Nordisk | 308.12B |
| UnitedHealth Group | 278.07B |
| Novartis AG | 240.15B |
| Abbott Laboratories | 232.67B |
| AstraZeneca | 216.19B |